Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Jun 16;11(3):00292-2025.
doi: 10.1183/23120541.00292-2025. eCollection 2025 May.

ERS Congress 2024: highlights from the Pulmonary Vascular Diseases Assembly

Vasile Foris  1   2 , Aleksandar Bokan  3 , Katarina Zeder  2   4 , Alessandra Cuomo  5 , Olivier Sitbon  6   7   8 , Anton Vonk Noordegraaf  9 , Mona Lichtblau  10 , Athénaïs Boucly  6   7   8
Affiliations
Editorial

ERS Congress 2024: highlights from the Pulmonary Vascular Diseases Assembly

Vasile Foris et al. ERJ Open Res. .

Abstract

This article highlights hot topics presented at the #ERSCongress 2024 on pulmonary embolism, right heart failure and personalised medicine for pulmonary hypertension https://bit.ly/3Yvb7VR.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: V. Foris reports a Mid-Career Grant from the Austrian Society of Pneumology, and a Max Kade Fellowship from the Max Kade Foundation; payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from Johnson & Johnson; and support for attending meetings from Boehringer Ingelheim, MSD, Johnson & Johnson, and the European Respiratory Society. K. Zeder reports a Max Kade Fellowship from the Max Kade Foundation, and grants or contracts from the Cardiovascular Medical Research and Education Fund (CMREF); consultancy fees from Ferrer and AstraZeneca; and support for attending meetings from Ferrer, Janssen and AOP. O. Sitbon reports grants or contracts from Aerovate, AOP Orphan, Ferrer, Janssen and MSD; consultancy fees from Altavant/Enzyvant, AOP Orphan, Ferrer, Gossamer Bio, Janssen, Liquidia, MSD, Respira Therapeutics, Roivant Sciences and United Therapeutics; payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from Aerovate, AOP Orphan, Janssen, Ferrer and MSD; and participation on a Data Safety Monitoring Board or Advisory Board for Altavant/Enzyvant, Gossamer Bio, Janssen and Respira Therapeutics. A. Boucly reports grants from Acceleron, Janssen and MSD; payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from Janssen, Merck, AOP Orphan, Ferrer, AstraZeneca, United Therapeutics and Gossamer; and support for attending meetings from Janssen, MSD, Ferrer and AOP Orphan. The remaining authors have nothing to disclose.

Similar articles

See all similar articles

References

    1. Lehnert P, Lange T, Møller CH, et al. Acute pulmonary embolism in a national Danish cohort: increasing incidence and decreasing mortality. Thromb Haemost 2018; 118: 539–546. doi: 10.1160/TH17-08-0531 - DOI - PubMed
    1. Naydenska S, Grudkov K, Stancheva B, et al. Comparative analysis and clinical application of imaging methods for diagnosis of pulmonary embolism. Eur Respir J 2024; 64: Suppl. 68, OA4568. doi: 10.1183/13993003.congress-2024.OA4568 - DOI
    1. Kabrhel C, Rosovsky R, Channick R, et al. A multidisciplinary Pulmonary Embolism Response Team: initial 30-month experience with a novel approach to delivery of care to patients with submassive and massive pulmonary embolism. Chest 2016; 150: 384–393. doi: 10.1016/j.chest.2016.03.011 - DOI - PubMed
    1. Lopez Ruz S, Barca Hernando M, García García V, et al. Catheter-directed therapies in patients with high-risk or intermediate-high-risk acute symptomatic pulmonary embolism with recent bleeding or high risk of bleeding. Analysis of implementing pulmonary embolism response team (PERT). Eur Respir J 2024; 64: Suppl. 68, OA5550. doi: 10.1183/13993003.congress-2024.OA5550 - DOI
    1. Shahwar D, Shekar K. Use of inhaled nitric oxide in submassive intermediate-risk pulmonary embolism: a single-centre experience. Eur Respir J 2024; 64: Suppl. 68, OA5555. doi: 10.1183/13993003.congress-2024.OA5555 - DOI

Publication types

LinkOut - more resources